A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
Bristol-Myers Squibb
Travera Inc
Eli Lilly and Company
OncoC4, Inc.
Bayer
AstraZeneca
Seagen Inc.
KaliVir Immunotherapeutics
Arcus Biosciences, Inc.
AstraZeneca
Sotio Biotech Inc.
Eli Lilly and Company
SystImmune Inc.
Rondo Therapeutics
Orano Med LLC
GI Innovation, Inc.
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
Alterome Therapeutics, Inc.
Neonc Technologies, Inc.
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Daiichi Sankyo
MacroGenics
Daiichi Sankyo
Adela, Inc
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Innate Pharma
Dren Bio
OncoNano Medicine, Inc.
Seagen Inc.
Tanabe Pharma America, Inc.
CRISPR Therapeutics
HiFiBiO Therapeutics
DualityBio Inc.
Massive Bio, Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Nurix Therapeutics, Inc.
Pfizer
Sensei Biotherapeutics, Inc.
Incyte Corporation
Merck Sharp & Dohme LLC
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.